Psychiatric Times

JUNE 23, 2025

SHOW MORE NRx Pharmaceuticals advances NRX-100, a preservative-free ketamine, through a fast-tracked FDA review for treating suicidal depression and PTSD. Sanom/Adobestock BREAKING NEWS A new formulation of ketamine is progressing through a novel US Food and Drug Administration review pathway, announced NRx Pharmaceuticals.

Pharmaceuticals 58

Pharmaceuticals Bipolar disorder Genetics and mental health Manufacturing 58

Mad in America

NOVEMBER 13, 2023

Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. 695 This is sickening.

Genetics and mental health 143

Genetics and mental health Aging and mental health Manufacturing Education 143

Mad in America

OCTOBER 18, 2023

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. This applies in the mental illness world and everywhere in medicine.

Pharmaceuticals 145

Pharmaceuticals Healthcare Manufacturing Neurotransmitters and mental health 145

Mad in America

AUGUST 3, 2024

Iatrogenesis is social when medicine as an institution and a bureaucracy creates ill-health by increasing stress; by subverting autonomy and community support; and by depoliticizing sources of illness. This alienation is of course quite stressful and a source of ill-health. The natural course of depression without any medication?

Genetics and mental health 142

Genetics and mental health Sleep and mental health Hospitality Technology 142